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1. INTRODUCTION {#cam42472-sec-0005}
===============

Several factors have been shown to influence survival in newly diagnosed cancer patients, including variables related to the tumor (size, grade, and biological characteristics, including molecular alterations), tumor stage, and those related to the nature and quality of treatment.[1](#cam42472-bib-0001){ref-type="ref"} Although these factors are useful in estimating survival and for treatment planning in the initial phase after diagnosis, these tend to be less helpful when it comes to predicting short‐term outcomes in advanced states of disease. Advanced cancer is defined as cancer that is unlikely to be cured or controlled with treatment (NCI dictionary) and treatment is primarily palliative to control symptoms. Common symptoms of advanced cancer include pain, nausea, and loss of appetite, tiredness, and breathlessness.[2](#cam42472-bib-0002){ref-type="ref"} This study is designed to help identify objective measures/factors that discriminate for more advanced disease presentations and can help to define the terminal phase of cancer. If we can define the terminal phase more objectively, we can communicate the prognosis more clearly and plan our treatment approach in accordance with the patient\'s wishes.

In regards to survival, individual cancer patients exhibit a remarkable amount of variation in outcomes. To understand this variation, researchers have attempted to identify clinical factors that can be used to predict the prognosis of individual cancer patients. The magnitude of this work is staggering with one literature review[3](#cam42472-bib-0003){ref-type="ref"} identifying 887 publications documenting 169 clinical, laboratory, and molecular prognostic factors in NSCLC patients. Despite the abundance of studies, results conflict on the importance of certain markers in predicting outcomes.[4](#cam42472-bib-0004){ref-type="ref"} Hence, only a few prognostic factors, such as extent of disease and performance status have been widely accepted and are used in clinical practice and defining the terminal phase in advanced cancer patients remains an ongoing challenge.

In the terminal phase, the clinical course of most cancers is fairly universal, with indicators of terminal disease, such as failing performance status, advanced age, weight loss, anorexia, hypercalcemia, malnutrition, and laboratory abnormalities, indicating widespread inflammation or extensive disease. Survival rates for these presentations have not significantly changed over the past 30 years, regardless of cancer type.[5](#cam42472-bib-0005){ref-type="ref"}

Cancer‐related morbidity and treatment‐related complications often result in a decompensation in which the cancer patient requires hospitalization. The average cancer patient spends about 5 weeks in the hospital during the last 6 months of life, and the terminal phase of the disease is associated with an exponential rise in hospitalization rate.[6](#cam42472-bib-0006){ref-type="ref"} Time trends in the rate of hospitalization of cancer patients over the last 6 months of life show that the proportion of patients hospitalized on any given day increases slowly, until approximately 3 months before death, but then increases at an accelerating rate as death approaches.[7](#cam42472-bib-0007){ref-type="ref"} Other more recent studies show that aggressiveness in end‐of‐life care for cancer patients is on the rise, which translates to more frequent and repeated hospital admissions, emergency department visits, and intensive care unit admissions.[8](#cam42472-bib-0008){ref-type="ref"} Another study reported that hospitalization may be underestimated in patients with advanced cancers. In patients with advanced cancer at the time of diagnosis (defined as stage IV for all cancers, stage IIIB for non‐small‐cell lung cancer, and stage III for pancreatic cancer), 71% were hospitalized at least once during the first year after diagnosis and 16% were hospitalized three times or more.[9](#cam42472-bib-0009){ref-type="ref"}

We believe that the first unplanned hospitalization event may be a harbinger that signals the transition to the terminal phase and a 30‐day readmission event signifies an even stronger decline in overall ability to respond to stress and necessitates a re‐evaluation of survival at the time of hospitalization. Most studies in cancer patients have attempted to model a limited number of factors to predict survival, and the prognostic models have been developed using poor methods which compromises the reliability and clinical relevance of the models, prognostic indices, and risk groups derived from them.[10](#cam42472-bib-0010){ref-type="ref"} This study will examine survival as a function of accumulated deficits---the index created will be used as a proxy measure of vulnerability to poor outcomes/mortality. As patients experience cancer‐related morbidity or treatment‐related complications requiring hospitalization, we believe that their survival is a function of accumulated deficits. The Rockwood method is a model based on the accumulation of deficits that proposes that as health deficits increase so do the risk of adverse outcomes.[11](#cam42472-bib-0011){ref-type="ref"} The concept that risk is related to deficit accumulation extends to a range of illnesses, including dementia,[12](#cam42472-bib-0012){ref-type="ref"} osteoporosis,[13](#cam42472-bib-0013){ref-type="ref"} and coronary heart disease.[14](#cam42472-bib-0014){ref-type="ref"} In these studies, deficit accumulation indicates increased disease expression and mortality risk. Deficits can be those outside of known risk factors for the disease and can include general health deficits and deficits related to special clinical populations and specific procedures. Laboratory tests and biomarkers have also been used as deficit indicators associated with risk of specific events.[15](#cam42472-bib-0015){ref-type="ref"}, [16](#cam42472-bib-0016){ref-type="ref"} An advantage to the deficit accumulation approach is that it allows multiple small effects, including ones that individually are not significantly associated with the outcome of interest, to add up. A deficit‐accumulation index to assess frailty in older patients undergoing chemotherapy was shown to be useful in predicting likelihood of experiencing chemotherapy‐related toxicities.[17](#cam42472-bib-0017){ref-type="ref"}

We evaluated 30‐day hospital readmission and accumulated deficits as predictors of survival in cancer patients with unanticipated hospital admissions. The DASI components, as listed in Table [1](#cam42472-tbl-0001){ref-type="table"}, were chosen based on literature review of known prognostic indicators and used together in accordance with the Rockwood Methodology.[11](#cam42472-bib-0011){ref-type="ref"} The factors chosen for the deficit‐accumulation survival index (DASI) included known prognostic indicators of cancer survival in the terminal cancer patient: markers of malnutrition (prognostic nutrition index \[PNI\],[18](#cam42472-bib-0018){ref-type="ref"} weight,[19](#cam42472-bib-0019){ref-type="ref"} and albumin level[20](#cam42472-bib-0020){ref-type="ref"}); inflammatory indices (neutrophil‐to‐lymphocyte ratio \[NLR\],[21](#cam42472-bib-0021){ref-type="ref"}, [22](#cam42472-bib-0022){ref-type="ref"}, [23](#cam42472-bib-0023){ref-type="ref"} platelet‐to‐lymphocyte ratio \[PLR\],[24](#cam42472-bib-0024){ref-type="ref"}, [25](#cam42472-bib-0025){ref-type="ref"}, [26](#cam42472-bib-0026){ref-type="ref"} and systemic immune‐inflammation index \[SII\][27](#cam42472-bib-0027){ref-type="ref"}); and biological factors (leukocytosis,[28](#cam42472-bib-0028){ref-type="ref"} hypercalcemia,[29](#cam42472-bib-0029){ref-type="ref"} lymphopenia,[30](#cam42472-bib-0030){ref-type="ref"} renal insufficiency,[31](#cam42472-bib-0031){ref-type="ref"}, [32](#cam42472-bib-0032){ref-type="ref"} and hyponatremia[33](#cam42472-bib-0033){ref-type="ref"}). Other factors of interest included type of cancer,[34](#cam42472-bib-0034){ref-type="ref"} health care utilization in the 6 months before the index admission, 30‐day readmission, length of index admission, presence of polypharmacy,[35](#cam42472-bib-0035){ref-type="ref"}, [36](#cam42472-bib-0036){ref-type="ref"} marital status as proxy for social support,[37](#cam42472-bib-0037){ref-type="ref"} fall risk,[38](#cam42472-bib-0038){ref-type="ref"} reason for index admission, reason for 30‐day readmission, Eastern Cooperative Oncology Group (ECOG) performance status (PS),[39](#cam42472-bib-0039){ref-type="ref"} and metastatic status.

###### 

Twenty‐three factors and cutoff levels utilized for the deficit‐accumulation

  Factor/cutoff level                                            Deficit
  -------------------------------------------------------------- ---------
  Readmission                                                     
  Yes                                                            1
  No                                                             0
  Marital status/support                                          
  Single/divorced/widowed                                        1
  Married                                                        0
  Language                                                        
  Not english                                                    1
  English                                                        0
  Fall risk                                                       
  High                                                           1
  Moderate/low                                                   0
  Health care utilization during prior 6 months (count visits)    
  \>2                                                            1
  \<2                                                            0
  BMI (kg/m^2^)                                                   
  \<19                                                           1
  \>19                                                           0
  Calcium corrected (mg/dL)                                       
  ≥11                                                            1
  \<11                                                           0
  Creatinine (mg/dL)                                              
  \>1.3                                                          1
  \<1.3                                                          0
  ECOG performance status                                         
  2, 3, 4                                                        1
  0, 1                                                           0
  NLR (index)                                                     
  \>5                                                            1
  \<5                                                            0
  Neutrophils (k/μL)                                              
  \<1.8                                                          1
  \>1.8                                                          0
  PLR (index)                                                     
  \>250                                                          1
  \<250                                                          0
  Platelet count (k/μL)                                           
  \>450 or \<150                                                 1
  150‐450                                                        0
  Hemoglobin (g/dL)                                               
  \<12                                                           1
  \>12                                                           0
  Length of index admission (days)                                
  \>5                                                            1
  \<5                                                            0
  Lymphocytes (k/μL)                                              
  \<1.1                                                          1
  \>1.1                                                          0
  SII (index)                                                     
  \>1600                                                         1
  \<1600                                                         0
  Albumin (g/dL)                                                  
  \<3.5                                                          1
  \>3.5                                                          0
  Sodium (mmol/L)                                                 
  \<135                                                          1
  \>135                                                          0
  WBC (k/μL)                                                      
  \>11                                                           1
  \<11                                                           0
  Number of medications (count)                                   
  \>5                                                            1
  \<5                                                            0
  PNI (index)                                                     
  \<45                                                           1
  \>45                                                           0
  Metastasis                                                      
  Yes                                                            1
  No                                                             0

Abbreviations: BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; NLR, neutrophil‐to‐lymphocyte ratio; PNI, prognostic nutrition index; PLR, platelet‐to‐lymphocyte ratio; SII, systemic immune‐inflammation index; WBC, white cell blood count.
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2. PATIENTS AND METHODS {#cam42472-sec-0006}
=======================

In this retrospective cohort study design, we identified patients who were admitted to the Internal Hospital Medicine (IHM) service at Moffitt Cancer Center between 01/01/16 and 09/30/16 with unplanned readmissions within 30 days of discharge from an index admission. To identify a control group, we ascertained the admission date of each study patient\'s index admission, which ranged from 12/26/15 to 09/14/16. A specific control patient who did not experience a readmission within 30 days of discharge was chosen as a match based on the proximity of his/her first day of admission to the date and time of a study patient\'s first day of admission. We identified 148 pairs of patients. On review, a few were not evaluable, resulting in 132 unplanned hospitalized patients (controls) and 139 patients with a readmission within 30‐day discharge. The last date of follow‐up/survival information was 4/13/2017.

Our center is a free‐standing comprehensive cancer center focused solely on the care of patients with a cancer diagnosis and their treatment. The Internal Hospital Medicine service admits patients for active cancer treatment, complications of cancer treatment, and morbidity associated with cancer. Patients with malignant hematologic diseases that have medical issues are rarely admitted to our service. For the purpose of this study, those with planned admissions were excluded from the 30‐day readmission cohort.

We collected the following clinical data from patient electronic medical records: length of stay of index admission, occurrence of a 30‐day readmission, days between readmission and discharge from index admission, age, marital status, language, reason for index admission, diagnosis(es) related to index admission, number of medications (scheduled and as needed) at discharge from index admission, number of admissions to our center in the 6 months before index admission, number of admissions to our center\'s intensive care unit in the 6 months before index admission, number of urgent care visits to our center\'s direct referral center in the 6 months before index admission, Morse fall risk level at time of index admission, weight, height, primary tumor site, number, and location of metastatic sites, ECOG PS, white blood cell count, hemoglobin level, platelet count, neutrophil count, lymphocyte count, serum sodium level, serum creatinine level, serum corrected calcium level, and serum albumin level.

We calculated NLR by dividing the number of neutrophils by the number of lymphocytes, the PLR by dividing the number of platelets by the number of lymphocytes, the SII by multiplying the PLR by the number of neutrophils, and the PNI by multiplying the albumin level by number of lymphocytes.

The reason for admission variable (chief complaint) was determined by review of patient history and physical assessment at time of admission. If there were multiple similar reasons for admission (chief complaints), these were then grouped for statistical analysis. The groupings are as follows: (a) pain (back pain, neoplasm‐related pain, abdominal pain); (b) neurologic complaints (syncope, dizziness, headache, diplopia, ataxia); (c) dyspnea (shortness of breath, hypoxia); (d) adverse effects of chemotherapy (nausea, vomiting, diarrhea within 1 week of chemotherapy); (e) abnormal findings on electrocardiogram, laboratory values, or radiographic imaging (combined group); and (f) other (any "reason" with count \<10). Regarding the variable of "cancer type," for any type with a count of \<10, it was grouped into the category of "other."

The outcome of interest was survival. The 23 factors used for DASI calculation and cutoff levels are shown in Table [1](#cam42472-tbl-0001){ref-type="table"}. This study was approved by the Chesapeake Institutional Review Board, which met the criteria for waiver of consent and of Health Insurance Portability and Accountability Act authorization.

2.1. Statistical analyses {#cam42472-sec-0007}
-------------------------

One goal of this analysis was to examine the relation between hospital readmission in cancer patients and overall survival. A Cox proportional hazards model tested time from initial hospital admission until death, with censoring at last follow‐up for living patients. A hazard ratio (HR) with a 95% confidence interval (CI) described the relation between hospital readmission and survival, with Kaplan‐Meier curves used to depict this relation. Also of interest was whether this relation remained statistically significant while accounting for other demographic (e.g. sex) and clinical (e.g. type of cancer) variables.

Univariate models were tested to determine which variables should be included in a single multivariable Cox model (*P* \< .05). NLR, neutrophil, PLR, platelet, and SII were all highly correlated; hence, only NLR was carried into multivariable analysis. Our multivariable model required the inclusion of cancer type, regardless of its statistical significance, to demonstrate that, in the terminal stage, the type of cancer does not play a prominent role in time to death. We also planned to include recent health care utilization regardless in the multivariable model. The outcome of interest in the multivariable model was the relation between hospital readmission and survival. With 271 patients, we were able to include as many as 13 covariates with minimal concern for model overfitting.[40](#cam42472-bib-0040){ref-type="ref"} We ended up including nine variables in the model.

Another goal of this study was to use an accumulation of deficits approach to predict survival. Deficits were summed across 23 factors and divided by the number of factors to create the DASI. DASI scores were then used to categorize patients into 3 groups: low (cutoff value of \<0.30), moderate (cutoff value of 0.31‐0.48), and high (cutoff value of \>0.48).

We used the Cox proportional hazards model and HR and 95% CI to describe the relation between deficit score and survival. A Kaplan‐Meier curve depicted this relation for the low, medium, and high deficit score groups. Data were analyzed using SAS 9.4 (SAS Institute Inc, Cary, NC).

With 271 patients, we had 80% statistical power to detect a hazard ratio of 1.54 or greater for the readmission outcome, and 1.69 or greater for the DASI outcome (assuming a 2‐sided test with a nominal alpha of 0.05).

3. RESULTS {#cam42472-sec-0008}
==========

Table [2](#cam42472-tbl-0002){ref-type="table"} shows characteristics of the 271 patients. The median age of patients was 63 years (range, 19‐92 years). Most patients were white (86%), English speaking (96%), and married (68%), with 51% male and 49% female.

###### 

Descriptive analysis

  Variable                                                 Level                    N = 266   \%
  -------------------------------------------------------- ------------------------ --------- ------
  Readmission (Y/N)                                        N                        132       49.6
  Y                                                        134                      50.4      
  Sex                                                      Female                   125       47.0
  Male                                                     141                      53.0      
  Marital status                                           Divorced                 27        10.3
  Married                                                  180                      69.0      
  Single                                                   33                       12.6      
  Widow                                                    21                       8.0       
  Missing                                                  5                        ---       
  Language                                                 English                  255       95.9
  Not English                                              11                       4.1       
  Race                                                     Not White                39        14.7
  White                                                    227                      85.3      
  Categorized Morse fall risk                              High                     103       39.3
  Low                                                      2                        0.8       
  Moderate                                                 148                      56.5      
  Universal                                                9                        3.4       
  Missing                                                  4                        ---       
  ECOG                                                     0                        26        15.4
  1                                                        105                      62.1      
  2                                                        25                       14.8      
  3                                                        13                       7.7       
  Missing                                                  97                       ---       
  General readmission reason category                      Cancer related           64        24.1
  General medical                                          95                       35.7      
  Treatment related                                        32                       12.0      
  Uncontrolled Sx                                          75                       28.2      
  Histology category                                       Carcinoma                195       73.6
  Melanoma                                                 20                       7.5       
  Other                                                    30                       11.3      
  Sarcoma                                                  20                       7.5       
  Missing                                                  1                        ---       
  Vital status                                             Alive                    157       59.0
  Dead                                                     109                      41.0      
  Metastasis                                               0                        99        38.4
  1                                                        159                      61.6      
  Missing                                                  8                        ---       
  Reason for admission                                     Abnormal EKG/Lab/Image   26        9.8
  Chemotherapy side effect                                 31                       11.7      
  Dehydration                                              11                       4.1       
  Dyspnea                                                  40                       15.0      
  Fever                                                    26                       9.8       
  Neurological Complaint                                   10                       3.8       
  Other                                                    63                       23.7      
  Pain                                                     59                       22.2      
  Cancer type                                              Bladder                  10        3.8
  Breast                                                   19                       7.1       
  GI                                                       61                       22.9      
  Head and neck                                            13                       4.9       
  Hepatocellular                                           7                        2.6       
  Lung                                                     48                       18.0      
  Melanoma                                                 21                       7.9       
  Neuroendocrine                                           8                        3.0       
  Other                                                    65                       24.4      
  Sarcoma                                                  14                       5.3       
  Clinic                                                   Breast                   19        7.1
  Cutaneous                                                25                       9.4       
  Endocrine                                                3                        1.1       
  GI                                                       86                       32.3      
  GU                                                       29                       10.9      
  Gyn                                                      2                        0.8       
  Head and neck                                            18                       6.8       
  Malignant heme                                           14                       5.3       
  Neuro‐onc                                                2                        0.8       
  Sarcoma                                                  19                       7.1       
  Thoracic                                                 49                       18.4      
  Age                                                      Mean                     61.63     ---
  Median                                                   63                       ---       
  Minimum                                                  19                       ---       
  Maximum                                                  87                       ---       
  SD                                                       13.05                    ---       
  Missing                                                  0                        ---       
  Health care visits previous 6 months                     Mean                     0.65      ---
  Median                                                   0                        ---       
  Minimum                                                  0                        ---       
  Maximum                                                  6                        ---       
  SD                                                       0.97                     ---       
  Missing                                                  0                        ---       
  BMI                                                      Mean                     26.50     ---
  Median                                                   25.86                    ---       
  Minimum                                                  14.76                    ---       
  Maximum                                                  57.15                    ---       
  SD                                                       6.39                     ---       
  Missing                                                  40                       ---       
  Corrected calcium                                        Mean                     9.57      ---
  Median                                                   9.50                     ---       
  Minimum                                                  7.50                     ---       
  Maximum                                                  16                       ---       
  SD                                                       0.91                     ---       
  Missing                                                  28                       ---       
  Creatinine                                               Mean                     1.02      ---
  Median                                                   0.80                     ---       
  Minimum                                                  0.20                     ---       
  Maximum                                                  7                        ---       
  SD                                                       0.77                     ---       
  Missing                                                  16                       ---       
  Days between current admission and index admission       Mean                     11.06     ---
  Median                                                   10                       ---       
  Minimum                                                  1                        ---       
  Maximum                                                  27                       ---       
  SD                                                       7.54                     ---       
  Missing                                                  ---                      ---       
  Karnofsky                                                Mean                     77.39     ---
  Median                                                   80                       ---       
  Minimum                                                  40                       ---       
  Maximum                                                  100                      ---       
  SD                                                       12.53                    ---       
  Missing                                                  124                      ---       
  Karnofsky score converted to ECOG                        Mean                     0.87      ---
  Median                                                   1                        ---       
  Minimum                                                  0                        ---       
  Maximum                                                  3                        ---       
  SD                                                       0.64                     ---       
  Missing                                                  124                      ---       
  Difference between ECOG score and Karnofsky conversion   Mean                     0.29      ---
  Median                                                   0                        ---       
  Minimum                                                  −2                       ---       
  Maximum                                                  3                        ---       
  SD                                                       0.82                     ---       
  Missing                                                  188                      ---       
  Height(cm)                                               Mean                     169       ---
  Median                                                   169                      ---       
  Minimum                                                  145                      ---       
  Maximum                                                  198                      ---       
  SD                                                       9.87                     ---       
  Missing                                                  34                       ---       
  Hemoglobin                                               Mean                     10.68     ---
  Median                                                   10.70                    ---       
  Minimum                                                  2                        ---       
  Maximum                                                  18.70                    ---       
  SD                                                       2.33                     ---       
  Missing                                                  5                        ---       
  Length of index admission (days)                         Mean                     4.88      ---
  Median                                                   3                        ---       
  Minimum                                                  0                        ---       
  Maximum                                                  63                       ---       
  SD                                                       5.89                     ---       
  Missing                                                  0                        ---       
  Lymphocytes                                              Mean                     1.59      ---
  Median                                                   0.87                     ---       
  Minimum                                                  0.080                    ---       
  Maximum                                                  104                      ---       
  SD                                                       7.16                     ---       
  Missing                                                  18                       ---       
  Morse fall risk                                          Mean                     47.47     ---
  Median                                                   45                       ---       
  Minimum                                                  0                        ---       
  Maximum                                                  100                      ---       
  SD                                                       18.11                    ---       
  Missing                                                  3                        ---       
  NLR                                                      Mean                     10.36     ---
  Median                                                   7.16                     ---       
  Minimum                                                  0.010                    ---       
  Maximum                                                  137                      ---       
  SD                                                       13.56                    ---       
  Missing                                                  46                       ---       
  Neutrophil                                               Mean                     7.07      ---
  Median                                                   5.73                     ---       
  Minimum                                                  0.010                    ---       
  Maximum                                                  33.24                    ---       
  SD                                                       4.77                     ---       
  Missing                                                  44                       ---       
  PLR                                                      Mean                     359       ---
  Median                                                   253                      ---       
  Minimum                                                  1.54                     ---       
  Maximum                                                  3089                     ---       
  SD                                                       370                      ---       
  Missing                                                  20                       ---       
  Platelet Count                                           Mean                     239       ---
  Median                                                   214                      ---       
  Minimum                                                  1                        ---       
  Maximum                                                  941                      ---       
  SD                                                       147                      ---       
  Missing                                                  5                        ---       
  SII                                                      Mean                     2546      ---
  Median                                                   1618                     ---       
  Minimum                                                  0.038                    ---       
  Maximum                                                  19 293                   ---       
  SD                                                       2938                     ---       
  Missing                                                  46                       ---       
  Albumin                                                  Mean                     3.42      ---
  Median                                                   3.40                     ---       
  Minimum                                                  0.30                     ---       
  Maximum                                                  7.40                     ---       
  SD                                                       0.71                     ---       
  Missing                                                  24                       ---       
  Sodium                                                   Mean                     136       ---
  Median                                                   136                      ---       
  Minimum                                                  116                      ---       
  Maximum                                                  157                      ---       
  SD                                                       4.98                     ---       
  Missing                                                  17                       ---       
  WBC                                                      Mean                     9.95      ---
  Median                                                   7.92                     ---       
  Minimum                                                  0.10                     ---       
  Maximum                                                  138                      ---       
  SD                                                       11.62                    ---       
  Missing                                                  5                        ---       
  Number of Medications on Admission                       Mean                     11.36     ---
  Median                                                   11                       ---       
  Minimum                                                  0                        ---       
  Maximum                                                  31                       ---       
  SD                                                       4.83                     ---       
  Missing                                                  4                        ---       
  PNI                                                      Mean                     42.53     ---
  Median                                                   39.05                    ---       
  Minimum                                                  6.85                     ---       
  Maximum                                                  549                      ---       
  SD                                                       38.05                    ---       
  Missing                                                  38                       ---       

Abbreviations: BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; NLR, neutrophilto‐lymphocyte ratio; PNI, prognostic nutrition index; PLR, platelet‐to‐lymphocyte ratio; SII, systemic immune‐inflammation index; WBC, white cell blood count.
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Patients with gastrointestinal cancers (23%) and lung cancers (16%) were most commonly represented among those who had an unplanned admission to our hospital (Table [2](#cam42472-tbl-0002){ref-type="table"}). Greater than 61% had documented metastatic disease; most patients were admitted with a chief complaint associated with common symptoms of advanced cancer (pain (21%), chemotherapy side effect (11%), dyspnea (15%), or fever (8%). However, reason for index admission was not a statistically significant predictor of survival in multivariable analysis (see Table [5](#cam42472-tbl-0005){ref-type="table"}).

Table [3](#cam42472-tbl-0003){ref-type="table"} compares each variable by 30‐day readmission. Few differences reached statistical significance (*P* \< .05). The few differences included age, with readmitted patients being slightly younger. The readmitted patients also had higher health care visits, length of index admission, medications, and NLR. Not surprisingly, the DASI was higher in readmitted patients.

###### 

Univariate comparison of all variables by cases and controls

  Covariate                              Statistics                 Level                    30‐d readmission (Y/N)   Parametric *P*‐value[\*](#cam42472-note-0005){ref-type="fn"}   
  -------------------------------------- -------------------------- ------------------------ ------------------------ -------------------------------------------------------------- ------------
  Sex                                    N (Col %)                  Female                   64 (48.48)               61 (45.52)                                                     .628
  N (Col %)                              Male                       68 (51.52)               73 (54.48)                                                                              
  Marital status                         N (Col %)                  Divorced                 16 (12.21)               11 (8.46)                                                      .122
  N (Col %)                              Married                    91 (69.47)               89 (68.46)                                                                              
  N (Col %)                              Single                     11 (8.4)                 22 (16.92)                                                                              
  N (Col %)                              Widow                      13 (9.92)                8 (6.15)                                                                                
  Language                               N (Col %)                  English                  128 (96.97)              127 (94.78)                                                    .369
  N (Col %)                              Not English                4 (3.03)                 7 (5.22)                                                                                
  Race                                   N (Col %)                  Not White                18 (13.64)               21 (15.67)                                                     .639
  N (Col %)                              White                      114 (86.36)              113 (84.33)                                                                             
  Categorized morse fall risk            N (Col %)                  High                     54 (40.91)               49 (37.69)                                                     .154
  N (Col %)                              Low                        0 (0)                    2 (1.54)                                                                                
  N (Col %)                              Moderate                   71 (53.79)               77 (59.23)                                                                              
  N (Col %)                              Universal                  7 (5.3)                  2 (1.54)                                                                                
  ECOG                                   N (Col %)                  0                        14 (17.72)               12 (13.33)                                                     .156
  N (Col %)                              1                          50 (63.29)               55 (61.11)                                                                              
  N (Col %)                              2                          7 (8.86)                 18 (20)                                                                                 
  N (Col %)                              3                          8 (10.13)                5 (5.56)                                                                                
  Admission reason                       N (Col %)                  Abnormal EKG/Lab/Image   9 (6.82)                 17 (12.69)                                                     .199
  N (Col %)                              Chemotherapy side effect   14 (10.61)               17 (12.69)                                                                              
  N (Col %)                              Dehydration                6 (4.55)                 5 (3.73)                                                                                
  N (Col %)                              Dyspnea                    26 (19.7)                14 (10.45)                                                                              
  N (Col %)                              Fever                      10 (7.58)                16 (11.94)                                                                              
  N (Col %)                              Neurological complaint     6 (4.55)                 4 (2.99)                                                                                
  N (Col %)                              Other                      28 (21.21)               35 (26.12)                                                                              
  N (Col %)                              Pain                       33 (25)                  26 (19.4)                                                                               
  Cancer type                            N (Col %)                  Bladder                  4 (3.03)                 6 (4.48)                                                       .532
  N (Col %)                              Breast                     10 (7.58)                9 (6.72)                                                                                
  N (Col %)                              GI                         38 (28.79)               23 (17.16)                                                                              
  N (Col %)                              Head and Neck              5 (3.79)                 8 (5.97)                                                                                
  N (Col %)                              Hepatocellular             2 (1.52)                 5 (3.73)                                                                                
  N (Col %)                              Lung                       22 (16.67)               26 (19.4)                                                                               
  N (Col %)                              Melanoma                   11 (8.33)                10 (7.46)                                                                               
  N (Col %)                              Neuroendocrine             4 (3.03)                 4 (2.99)                                                                                
  N (Col %)                              Other                      28 (21.21)               37 (27.61)                                                                              
  N (Col %)                              Sarcoma                    8 (6.06)                 6 (4.48)                                                                                
  Histology category                     N (Col %)                  Carcinoma                101 (77.1)               94 (70.15)                                                     .583
  N (Col %)                              Melanoma                   8 (6.11)                 12 (8.96)                                                                               
  N (Col %)                              Other                      14 (10.69)               16 (11.94)                                                                              
  N (Col %)                              Sarcoma                    8 (6.11)                 12 (8.96)                                                                               
  Clinic                                 N (Col %)                  Breast                   10 (7.58)                9 (6.72)                                                       .920
  N (Col %)                              Cutaneous                  13 (9.85)                12 (8.96)                                                                               
  N (Col %)                              Endocrine                  1 (0.76)                 2 (1.49)                                                                                
  N (Col %)                              GI                         46 (34.85)               40 (29.85)                                                                              
  N (Col %)                              GU                         12 (9.09)                17 (12.69)                                                                              
  N (Col %)                              Gyn                        0 (0)                    2 (1.49)                                                                                
  N (Col %)                              Head and Neck              9 (6.82)                 9 (6.72)                                                                                
  N (Col %)                              Malignant heme             8 (6.06)                 6 (4.48)                                                                                
  N (Col %)                              Neuro‐onc                  1 (0.76)                 1 (0.75)                                                                                
  N (Col %)                              Sarcoma                    10 (7.58)                9 (6.72)                                                                                
  N (Col %)                              Thoracic                   22 (16.67)               27 (20.15)                                                                              
  DASI                                   N (Col %)                  HIG                      25 (18.94)               54 (40.3)                                                      **\<.001**
  N (Col %)                              MOD                        69 (52.27)               64 (47.76)                                                                              
  N (Col %)                              LOW                        38 (28.79)               16 (11.94)                                                                              
  Metastasis                             N (Col %)                  0                        49 (37.98)               50 (38.76)                                                     .898
  N (Col %)                              1                          80 (62.02)               79 (61.24)                                                                              
  Age                                    N                                                   132                      134                                                            **.048**
  Mean                                                              63.22                    60.06                                                                                   
  Median                                                            65                       63                                                                                      
  Health care visits previous 6 months   N                                                   132                      134                                                            **.045**
  Mean                                                              0.53                     0.77                                                                                    
  Median                                                            0                        0                                                                                       
  SCMC visits previous 6 months          N                                                   132                      134                                                            .232
  Mean                                                              0.25                     0.42                                                                                    
  Median                                                            0                        0                                                                                       
  Weight                                 N                                                   124                      133                                                            .630
  Mean                                                              77.47                    76.24                                                                                   
  Median                                                            72.85                    74.7                                                                                    
  Corrected Calcium                      N                                                   119                      119                                                            .258
  Mean                                                              9.51                     9.64                                                                                    
  Median                                                            9.5                      9.5                                                                                     
  Creatinine                             N                                                   124                      126                                                            .959
  Mean                                                              1.02                     1.02                                                                                    
  Median                                                            0.8                      0.8                                                                                     
  ECOG                                   N                                                   79                       90                                                             .592
  Mean                                                              1.11                     1.18                                                                                    
  Median                                                            1                        1                                                                                       
  Karnofsky                              N                                                   68                       74                                                             .568
  Mean                                                              76.76                    77.97                                                                                   
  Median                                                            80                       80                                                                                      
  Hemoglobin                             N                                                   129                      132                                                            .868
  Mean                                                              10.66                    10.7                                                                                    
  Median                                                            10.8                     10.65                                                                                   
  Length of index admission (days)       N                                                   132                      134                                                            **\<.001**
  Mean                                                              3.61                     6.12                                                                                    
  Median                                                            3                        4                                                                                       
  Lymphocytes                            N                                                   119                      129                                                            .773
  Mean                                                              1.45                     1.71                                                                                    
  Median                                                            0.96                     0.77                                                                                    
  NLR                                    N                                                   112                      108                                                            **.018**
  Mean                                                              8.23                     12.56                                                                                   
  Median                                                            6.22                     7.73                                                                                    
  Neutrophil                             N                                                   113                      109                                                            .132
  Mean                                                              6.59                     7.56                                                                                    
  Median                                                            5.5                      6.35                                                                                    
  PLR                                    N                                                   119                      127                                                            .858
  Mean                                                              363.37                   354.89                                                                                  
  Median                                                            250                      268.24                                                                                  
  Platelet count                         N                                                   129                      132                                                            .598
  Mean                                                              243.63                   234.02                                                                                  
  Median                                                            208                      218.5                                                                                   
  SII                                    N                                                   112                      108                                                            .282
  Mean                                                              2336.75                  2763.63                                                                                 
  Median                                                            1400.96                  2056.93                                                                                 
  Albumin                                N                                                   121                      121                                                            .119
  Mean                                                              3.49                     3.35                                                                                    
  Median                                                            3.5                      3.4                                                                                     
  Sodium                                 N                                                   124                      125                                                            .951
  Mean                                                              135.86                   135.82                                                                                  
  Median                                                            136                      136                                                                                     
  WBC                                    N                                                   129                      132                                                            .952
  Mean                                                              9.99                     9.9                                                                                     
  Median                                                            7.99                     7.74                                                                                    
  Weight                                 N                                                   124                      133                                                            .630
  Mean                                                              77.47                    76.24                                                                                   
  Median                                                            72.85                    74.7                                                                                    
  Number of medications on admission     N                                                   131                      131                                                            **.019**
  Mean                                                              10.66                    12.06                                                                                   
  Median                                                            10                       12                                                                                      
  PNI                                    N                                                   112                      116                                                            .987
  Mean                                                              42.57                    42.49                                                                                   
  Median                                                            39.28                    38.63                                                                                   

Abbreviations: BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; NLR, neutrophilto‐lymphocyte ratio; PNI, prognostic nutrition index; PLR, platelet‐to‐lymphocyte ratio; SII, systemic immune‐inflammation index; WBC, white cell blood count.

Bold values significance *P* values \<0.05.

The parametric *P*‐value is calculated by ANOVA for numerical covariates and chi‐square test for categorical covariates.

John Wiley & Sons, Ltd

A 30‐day readmission event was strongly associated with survival, with an adjusted hazard ratio (HR) of 2.39% and a 95% confidence interval (CI) of 1.46‐3.92. Patients who were readmitted within 30 days of discharge from their index admission had a median survival of 147 days compared with patients not readmitted who had not reached median survival by the end of the study (*P* \< .0001) (Figure [1](#cam42472-fig-0001){ref-type="fig"}). In addition to 30‐day readmission, other significant predictors of survival identified in univariate Cox regression analyses included ECOG PS, metastasis, corrected calcium, length of index admission, inflammation indices (NLR, PLR, and SII), PNI, and leukocytosis (WBCs) (Table [4](#cam42472-tbl-0004){ref-type="table"}). Also notable, certain reasons for index admission (chemotherapy side effect, dehydration, neurological complaints, and "other" conditions); and two types of cancer (bladder and hepatocellular) were statistically significant predictors of survival. In the final multivariable Cox model, factors remaining statistically significant were 30‐day readmission event (HR = 2.44; 95% CI = 1.44‐4.12), corrected calcium, PNI, and leukocytosis (WBCs) (Table [5](#cam42472-tbl-0005){ref-type="table"}). To test whether missing data biased our results, we created 20 datasets with complete data using multiple imputations to estimate missing values. We tested these 20 datasets on the final multivariate Cox regression model. The range of the hazard ratios for readmission using these 20 tests was: 1.8‐2.0. All were statistically significant at the *P* ≤ .01 level.

![Kaplan‐Meier survival curves for overall survival according to 30‐d readmission category for 271 patients](CAM4-8-6503-g001){#cam42472-fig-0001}

###### 

Univariate survival analysis

  Covariate                                            Level                    N                  Hazard Ratio (95% CI)   HR *P*‐value
  ---------------------------------------------------- ------------------------ ------------------ ----------------------- ----------------
  Sex                                                  Female                   132                0.99 (0.69‐1.43)        .971
  Male                                                 139                      ---                ---                     
  Marital status                                       Divorced                 28                 0.87 (0.47‐1.60)        .644
  Single                                               35                       0.71 (0.39‐1.31)   .272                    
  Widow                                                22                       1.33 (0.72‐2.45)   .361                    
  Married                                              180                      ---                ---                     
  Language                                             Not English              11                 1.12 (0.41‐3.03)        .830
  English                                              260                      ---                ---                     
  Race                                                 Not White                38                 1.05 (0.61‐1.82)        .850
  White                                                233                      ---                ---                     
  Categorized morse fall risk                          Low                      2                  0.00 (0.00‐.)           .983
  Moderate                                             150                      0.71 (0.49‐1.03)   .074                    
  Universal                                            10                       0.14 (0.02‐1.04)   .055                    
  High                                                 105                      ---                ---                     
  ECOG                                                 1                        109                1.37 (0.64‐2.94)        .413
  2                                                    28                       2.15 (0.89‐5.19)   .088                    
  3                                                    15                       2.54 (0.99‐6.49)   .052                    
  0                                                    23                       ---                ---                     
  Reason for admission                                 Abnormal EKG/Lab/Image   26                 0.64 (0.32‐1.27)        .201
  Chemotherapy Side Effect                             30                       0.48 (0.23‐0.98)   **.045**                
  Dehydration                                          11                       0.21 (0.05‐0.89)   **.035**                
  Dyspnea                                              41                       0.98 (0.57‐1.69)   .937                    
  Fever                                                21                       0.54 (0.25‐1.18)   .123                    
  Neurological Complaint                               8                        0.13 (0.02‐0.93)   **.042**                
  Other                                                78                       0.59 (0.35‐0.99)   **.044**                
  Pain                                                 56                       ---                ---                     
  Cancer type                                          Bladder                  9                  3.96 (1.46‐10.74)       **.007**
  Breast                                               16                       0.84 (0.33‐2.09)   .702                    
  GI                                                   62                       1.17 (0.66‐2.09)   .584                    
  Head and neck                                        13                       1.42 (0.56‐3.55)   .459                    
  Hepatocellular                                       7                        2.86 (1.14‐7.21)   **.025**                
  Melanoma                                             22                       0.80 (0.35‐1.83)   .590                    
  Neuroendocrine                                       8                        0.26 (0.03‐1.93)   .187                    
  Other                                                76                       0.89 (0.50‐1.59)   .697                    
  Sarcoma                                              14                       0.75 (0.26‐2.22)   .608                    
  Lung                                                 44                       ---                ---                     
  Histology category                                   Melanoma                 22                 0.80 (0.39‐1.65)        .548
  Other                                                29                       1.02 (0.57‐1.83)   .943                    
  Sarcoma                                              22                       0.71 (0.33‐1.54)   .385                    
  Carcinoma                                            197                      ---                ---                     
  Dasi                                                 Moderate                 139                1.88 (1.00‐3.52)        **.049**
  High                                                 84                       4.71 (2.48‐8.95)   **\<.001**              
  Low                                                  48                       ---                ---                     
  Metastasis                                           Yes                      159                1.79 (1.19‐2.70)        **.005**
  No                                                   103                      ---                ---                     
  Readmission (Y/N)                                    Yes                      139                2.08 (1.42‐3.05)        **\<.001**
  No                                                   132                      ---                ---                     
  Age                                                                           271                1.01 (0.99‐1.02)        .286
  Health care visits previous 6 months                                          271                1.06 (0.89‐1.25)        .532
  SCMC visits previous 6 months                                                 271                0.94 (0.78‐1.13)        .514
  Weight                                                                        265                0.99 (0.98‐1.00)        .154
  Corrected calcium (Log transformed)                                           244                145.28 (23.09‐914.27)   **\<**.**001**
  Creatinine (Log Transformed)                                                  255                0.74 (0.31‐1.75)        .487
  Days between current admission and index admission                            139                1.00 (0.97‐1.03)        .829
  ECOG                                                                          175                1.39 (1.07‐1.82)        **.015**
  Karnofsky                                                                     151                0.99 (0.97‐1.01)        .507
  Height(cm)                                                                    240                1.00 (0.98‐1.02)        .679
  Hemoglobin                                                                    267                1.02 (0.94‐1.11)        .628
  Length of index admission(days)(Log Transformed)                              271                1.33 (1.02‐1.73)        **.034**
  Lymphocytes                                                                   254                0.86 (0.63‐1.19)        .359
  NLR (Log transformed)                                                         226                1.71 (1.36‐2.16)        **\<**.**001**
  Neutrophil (Log transformed)                                                  227                2.41 (1.66‐3.50)        **\<**.**001**
  PLR (Log transformed                                                          252                1.34 (1.08‐1.67)        **.008**
  Platelet count (Log transformed)                                              267                1.58 (1.15‐2.15)        **.004**
  SII (Log transformed)                                                         225                1.65 (1.36‐2.00)        **\<**.**001**
  Albumin                                                                       248                0.53 (0.40‐0.72)        **\<**.**001**
  PNI                                                                           234                0.95 (0.93‐0.98)        **\<**.**001**
  Sodium                                                                        254                0.99 (0.95‐1.03)        0.503
  WBC (Log transformed)                                                         267                1.45 (1.13‐1.85)        **.004**
  Weight                                                                        265                0.99 (0.98‐1.00)        .154
  Number of diagnoses (Log transformed)                                         265                0.99 (0.98‐1.00)        .154
  Number of medications on admission                                            267                1.01 (0.97‐1.05)        .807

Abbreviations: BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; NLR, neutrophilto‐lymphocyte ratio; PNI, prognostic nutrition index; PLR, platelet‐to‐lymphocyte ratio; SII, systemic immune‐inflammation index; WBC, white cell blood count.

Bold values significance *P* values \<0.05.
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###### 

Multivariable survival analysis

  Covariate                                          Level                    Hazard ratio        HR *P*‐value
  -------------------------------------------------- ------------------------ ------------------- --------------
  Readmission (Y/N)                                  Yes                      2.44 (1.44‐4.12)    **\<.001**
  No                                                 ---                      ---                 
  Health care visits previous 6 months                                        0.95 (0.75‐1.20)    .672
  Cancer type                                        Bladder                  2.79 (0.69‐11.30)   .150
  Breast                                             1.03 (0.34‐3.07)         .961                
  GI                                                 1.27 (0.58‐2.80)         .553                
  Head and Neck                                      2.22 (0.64‐7.66)         .207                
  Hepatocellular                                     4.74 (0.42‐53.14)        .207                
  Melanoma                                           0.65 (0.26‐1.65)         .366                
  Neuroendocrine                                     0.47 (0.06‐3.96)         .486                
  Other                                              1.46 (0.66‐3.24)         .351                
  Sarcoma                                            0.93 (0.26‐3.29)         .914                
  Lung                                               ---                      ---                 
  Metastasis                                         Yes                      1.35 (0.79‐2.30)    .266
  No                                                 ---                      ---                 
  Reason for admission                               Abnormal EKG/Lab/Image   0.75 (0.27‐2.09)    .580
  Chemotherapy side effect                           1.08 (0.46‐2.53)         .859                
  Dehydration                                        0.32 (0.07‐1.56)         .160                
  Dyspnea                                            0.94 (0.42‐2.12)         .887                
  Fever                                              0.47 (0.16‐1.41)         .179                
  Neurological complaint                             0.61 (0.08‐4.93)         .647                
  Other                                              0.80 (0.41‐1.55)         .508                
  Pain                                               ---                      ---                 
  Corrected calcium                                                           1.55 (1.16‐2.06)    **.003**
  Length of index admission(days)(Log transformed)                            0.87 (0.60‐1.26)    .464
  NLR (Log transformed)                                                       0.83 (0.54‐1.30)    .423
  PNI                                                                         0.94 (0.90‐0.99)    **.013**
  WBC (Log transformed)                                                       2.21 (1.18‐4.12)    **.013**

John Wiley & Sons, Ltd

The DASI was a prominent predictor of survival. Relative to results in the low‐score group, hazard ratios in the moderate‐ and high‐score groups were 1.88 (95% CI, 1.00‐3.53; *P* = .049) and 4.71 (95% CI, 2.48‐8.95; *P* = .0001). The median survival time was 78 days (95% CI, 61‐131 days) for the high‐score group (cutoff value \> 0.48), 318 days (95% CI, 207‐426 days) for the moderate‐score group (cutoff value, 0.31‐0.48), and not reached as of 426 days (*P* \< .001) for the low‐score group (cutoff value \< 0.31) (Figure [2](#cam42472-fig-0002){ref-type="fig"}).

![Kaplan‐Meier survival curves for overall survival in 271 patients](CAM4-8-6503-g002){#cam42472-fig-0002}

4. DISCUSSION {#cam42472-sec-0009}
=============

Providing survival estimates is important for decision making in oncology care. Our anecdotal experience tells us that an unplanned acute hospitalization can signify a deterioration of performance status, often indicating a serious worsening of prognosis. However, being able to quantify this change in prognosis objectively has remained elusive. Our methodologic approach to estimate survival at the time of unplanned hospitalization and 30‐day readmission supports our experience. For patients with unplanned hospitalization followed by readmission within 30 days, median survival was 147 days. This worsening of survival in readmitted patients supports the use of readmission as a signal of the transition from the progressive to the terminal cancer phase.

For patients in our study group, factors associated with survival were not cancer specific, nor were they specific to the admitting diagnosis at the time of hospitalization, when combined with readmission in a multivariable statistical model. Rather, they represented general features common to the terminal cancer patient, such as widespread inflammation, malnutrition, biological disarrangements (such as hypercalcemia and leukocytosis). Correlations observed between NLR, PLR, and SII, but not PNI, suggested that the different inflammation indices were measuring the same thing in our study and suggested that PNI might be measuring a separate factor (malnutrition or cachexia). The identification of common features across cancer types supports the notion that the course of most cancers eventuates in a fairly universal clinical picture.

As a further refinement to our survival estimation, our formulated DASI system was found to be highly effective in predicting survival. The high‐score group had a median survival of 78 days vs \>426 days in the low‐score group. Identifying patients who fall into the high‐score category will allow us to have a robust and timely discussion about end‐of‐life planning without having patients undergo unnecessary and costly medical interventions. To our knowledge, this is the first time this approach has been applied to cancer patients at the time of unplanned hospitalization. Our next step will be to prospectively validate this approach with attention to limitations related to existing clinical documentation.

Although our cohort mostly comprised patients with gastrointestinal and lung cancers and those having pain and dyspnea as their chief complaint, these factors were not statistically significant drivers of survival in our study. This is consistent with observations that quality of life indicators (including nausea and emesis, dyspnea, pain, and weakness) provide prognostic clues in patients with terminal cancer. Symptoms of dyspnea and pain may reflect progress of patients toward this terminal syndrome.[41](#cam42472-bib-0041){ref-type="ref"}

A significant limitation is that our data were limited to those available in the electronic medical record. In certain instances, we used existing data such as nursing documentation of fall risk as a proxy for debility/robustness of the individual. We recognize that a true objective measure would be more informative, such as the validated Timed Up and Go study.[42](#cam42472-bib-0042){ref-type="ref"} We utilized "marital status" as a proxy for social support in lieu of the validated Social Support Questionnaire.[43](#cam42472-bib-0043){ref-type="ref"} We also recognize that we did not have adequate data on comorbidities and that implementation of tools such as the Charlson Comorbidity Index[44](#cam42472-bib-0044){ref-type="ref"} would be helpful. Hence, the fact that these variables were not significant in our analysis could be more a function of the limitations of our available data.

Although ECOG PS has long been accepted as a strong predictor of survival in cancer patients and was a significant predictor in our univariate analysis, our ECOG PS data may perhaps be not generalizable. The ECOG PS data were missing in 36% (186/287) of our cohort and 76% (142/186) had a documented ECOG PS of 1 or 0. The low ECOG PS may not be representative of the true clinical status of patients at the time of unplanned hospitalization. Because of lack of good quality data, we omitted ECOG PS from the multivariable analysis.

This study focused on patients receiving care at our free‐standing oncology center, resulting in limitations related to a lack of diversity among patients and lack of data for health care utilization at other sites. We recognize that further study is required to include cancer patients receiving care beyond our institution and service area.

This study represents a significant advancement in the methodology for assessment of survival at the time of unplanned hospitalization. We found that unplanned hospitalization followed by a 30‐day readmission event and our DASI system were important predictors of survival. The identified deficits found to be significant represent features common to the terminal cancer patient, such as widespread inflammation, malnutrition, biological disarrangements, and increased health care utilization. Utilization of a 30‐day readmission event and the DASI system could improve our current means of survival estimation in cancer patients with unplanned hospitalization. Future work will focus on prospective validation of our model with attention to overcome the limitations described above.
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